Objective To determine the proportion of children aged <2 years who have been asphyxiated presenting with epistaxis in the absence of trauma or medical explanation and to identify the characteristics of the clinical presentation indicative of asphyxiation.
A lthough epistaxis is a frequent and often trivial finding in children, owing predominantly to trauma, congenital disorders, nasal mucosal abnormalities, and coagulation disorders, it is extremely rare in those aged <2 years, with an incidence of up to 31 per 10 000 children. [1] [2] [3] [4] In a landmark study, epistaxis was observed in 37% of infants who were asphyxiated using covert surveillance. 5 Consequently, epistaxis has been described as a marker of asphyxiation in very young children. 6 The challenge is to distinguish between epistaxis from benign causes and epistaxis from asphyxiation. In the US, more than 1.25 million children experience maltreatment annually. 7 Asphyxiation is a recognized form of fatal maltreatment. Although it is associated with high morbidity and mortality, asphyxiation may present with few or no external signs. 8 Child homicide is most frequent in infancy 9 ; therefore, evaluating the likelihood of asphyxiation in young children, such as those presenting with epistaxis, is of paramount importance in identifying children at significant risk of further harm or death. 8 Whether asphyxiation has occurred intentionally or unintentionally, the challenge is to find clinical indicators that asphyxiation may be associated with the child's epistaxis.
The physiological mechanism underlying epistaxis in asphyxia is complex, which has led to controversy surrounding the use of epistaxis as an indicator of asphyxia. 3, [10] [11] [12] The significance of epistaxis as an indicator of asphyxiation is particularly pertinent in a legal setting, as for example in a 2000 case in England, where the expert witnesses disagreed as to the relative significance of previous epistaxis as a possible indicator of repeated imposed asphyxiation. 13 The consequences of an incorrect decision either way has significant implications for the affected family.
Individual studies have aimed to define the relationship between epistaxis and asphyxiation, but given the rarity of the problem in infancy, they are necessarily small, with a high potential for bias. This systematic review aimed to address this situation by identifying associated features of epistaxis indicative of asphyxiation in children aged <2 years.
Methods
An all-language search was conducted of published and gray literature across 10 databases from 1900 to 2015 (Table I ; available at www.jpeds.com). The search strategy, developed in MEDLINE Ovid, consisted of 76 key words and Medical Subject Headings (Table II ; available at www.jpeds.com). This was adapted for other databases. Supplementary "snowballing" techniques were used to augment search sensitivity including searching non-indexed journals, searching the references of all full-text articles, and correspondence with authors of included studies when necessary for clarification of clinical or social details.
Inclusion criteria were age <2 completed years with epistaxis, encompassing live and fatal cases. Epistaxis was defined as any nasal bleeding, which included oronasal bleeding but not serosanguinous secretions in fatal cases. Asphyxiation included intentional and unintentional upper airway obstruction. 14, 15 Included study designs were cross-sectional, cohort, and case series with at least 3 cases (Table III ; available at www.jpeds.com). Exclusion criteria included traumatic epistaxis or medical conditions that predispose to epistaxis, oral bleeding, case reports, review articles, expert opinion, studies in which adult and child data could not be separated, methodologically flawed studies, studies that used the presence of epistaxis to confirm asphyxiation, and studies that addressed epistaxis only in the absence of asphyxiation.
Data were extracted under the following headings: ascertainment, study population, clinical characteristics/presentation, coexistent injuries, past or subsequent medical histories, sibling medical histories, confirmation of asphyxiation, exclusion of asphyxiation, and exclusion of trauma and organic disease (Table IV) .
Studies were assessed for inclusion, reviewed, and critically appraised independently by 2 reviewers, and disagreements were resolved by third reviewer arbitration. Studies were evaluated using a standardized critical appraisal tool that included 10 domains (Figure 1 ; available at www.jpeds.com). 20, 21 This review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. 22 A ranking of asphyxiation confirmation and exclusion was designed to minimize circularity, that is, to exclude studies that used the presence of epistaxis to confirm asphyxiation, and to exclude studies that did not adequately detail how asphyxiation was confirmed or excluded in a child with epistaxis ( Table V) . Only studies with an asphyxiation ranking between 1 and 3 were included. This required asphyxiation to be witnessed or admitted by the perpetrator, or to be determined by multiagency child protection groups, postmortem, sudden death investigations, or legal panels.
Data Analyses
We compared children who had adequate confirmation of asphyxia and epistaxis with children who had epistaxis but had not been asphyxiated ( Table V) . The proportion of children presenting with epistaxis who had been asphyxiated, along with the associated 95% CI, was calculated for each study. When 2 publications from the same study were identified, we approached the authors to identify duplicate cases, which were removed from the analysis to prevent double-counting. We calculated the proportion of children with epistaxis who had been asphyxiated, and also performed a descriptive analysis of the associated features of children with asphyxiation-related epistaxis.
Results
Out of the 2706 articles identified, 7 articles (6 studies) were included, representing 30 young children with asphyxiationrelated epistaxis and 74 children with non-asphyxia-related epistaxis (Table IV and Figure 2 ; Figure 2 available at www.jpeds.com). 2, 4, 5, [16] [17] [18] [19] Children with non-asphyxiarelated epistaxis and concurrent upper respiratory tract infection that was not considered a definitive medical cause of epistaxis, as confirmed by the authors when necessary, were included. 4, 19 Two publications from the same study were clarified with the authors to avoid duplication of cases for statistical analysis. 4, 19 Included studies were cross-sectional and case-series designs, largely recorded by covert surveillance, autopsy reports, death scene investigations, and medical records. 2, 4, 5, [16] [17] [18] [19] There was no clear differential presentation of age between those with asphyxiation-related epistaxis and those with non-asphyxia-related epistaxis (Table VI; available at www. jpeds.com). Children with asphyxiation-related epistaxis (n = 30) were aged 30 to 684 days (1 child aged >1 year), and those with non-asphyxia-related epistaxis (n = 74) were aged 10 to 398 days (1 child aged >1 year). Age ranges were affected by the various studies' inclusion criteria (Table IV) . Only 14 of 49 live children with epistaxis were recorded as undergoing clotting investigation. 2, 4, 5, [16] [17] [18] [19] Of the 6 included studies, 2, 4, 5, [16] [17] [18] [19] 3 were comparative 2, 4, 17, 19 (ie, included 2 groups of children, 1 group with epistaxis with asphyxia and 1 group with epistaxis without asphyxia), and thus provided estimates of the proportion of children presenting with epistaxis who had been asphyxiated, which was between 7% and 24% ( Table VII) . Krous et al reported a proportion of 16.7% (95% CI, 7%-36%), McIntosh et al reported a proportion of 24% (95% CI, 12%-43%), and Paranjothy et al reported a proportion of 7.1% (95% CI, 1%-32%).
Of the 30 children who were asphyxiated, 17 presented alive, aged 30 to 684 days (1 child aged >1 year), and 13 were dead on arrival, aged 32 to 324 days (Table IV) . Reported mechanisms of asphyxiation included overlaying, positional, and mechanical asphyxiation with clothing, bedding, and hands.
The clinical presentation of the 17 live children who wereasphyxiated was adequately described by 3 studies in 4 publications. 4, 5, 16, 19 There was variability in the features described in these children (Table IV) , with some presenting as pale, Volume 168 January 2016 sweaty, and tachycardic and others presenting as lifeless, bradycardic, shocked, and acidotic, possibly related to the severity of insult or timing of presentation. 4, 5, 19 Children presented with skin color changes (pallor or cyanosis), respiratory and cardiac symptoms, and chest radiograph abnormalities (eg, opacities, patchiness without associated upper respiratory tract infection, pneumothorax, pneumomediastinum) characteristic of asphyxiation (Table IV) . 4, 5, 19 Some children with abnormal pallor or respiration were also acidotic on presentation (n = 3) and had a capillary refill time $5 seconds (n = 2), with tachycardia (n = 1) or bradycardia (n = 3). A few live children who were asphyxiated were reported to have coexistent injuries that included petechiae of the head and neck (n = 2), 5, 19 facial bruising (n = 1), 19 and hypoxicischemic changes on magnetic resonance imaging (n = 1). 2 Three studies described children with epistaxis who presented dead on arrival with confirmed asphyxia (n = 13). [16] [17] [18] Postmortem signs in the children who were asphyxiated included intrapulmonary hemorrhage (n = 10/11-this was not specified for two cases) and intrathoracic/pleural petechiae (3 of the 13 children had these petechiae, four did not, and it was not possible to extract this information for the remaining 6 cases). However, petechiae were present in the children who were not asphyxiated as well. These were identified and quantified histologically on hematoxylin and eosin-stained lung sections. [16] [17] [18] In the studies where previous and subsequent medical histories were described, repeated presentations were typical and varied (Table IV) . One study described 4 children with asphyxiation-related epistaxis who had previous hospital admissions for apparent life-threatening events (ALTEs). 16 Similarly, in a study reported by Southall et al, 5 all 8 children undergoing covert video surveillance had a history of recurrent ALTEs as a prerequisite for inclusion in the study. The frequency of these ALTEs per infant ranged from 5 to 10. Two children experienced respiratory difficulties during or after ALTEs. One parent was observed fracturing the ulna and radius of an infant with a history of ALTEs and associated epistaxis. Four children who were asphyxiated presenting with epistaxis included in this review had recurrent epistaxis, defined as additional previous or subsequent history of epistaxis. One of these previous incidences of epistaxis was associated with "nearmiss" sudden infant death syndrome (SIDS). 4, 5 Sibling medical histories were varied (Table IV) . Three children who were asphyxiated had siblings who had died; 2 of these deaths were previously classified as SIDS. 5, 16 The death of 1 sibling with oral bleeding, originally classified as SIDS, was later deemed to have been a homicide. 16 Non-asphyxia-related epistaxis was described for 32 live children, although the clinical presentation of these children was rarely described. 2, 4, [17] [18] [19] Four of these 32 children presented with ALTEs, including apnea, irritability, and abnormal pallor. 19 All 42 deceased children with non-asphyxia-related epistaxis underwent postmortem forensic investigation and 17, 18 Most deceased children with non-asphyxia-related epistaxis (n = 41/42) were classified as having SIDS, some were bed-sharing (n = 9), and they were found supine (n = 6) and prone (n = 4). 17, 18 Epistaxis occurred before (n = 11), after (n = 9), and in the absence of (n = 1) cardiopulmonary resuscitation (CPR) in this group. Pulmonary hemorrhage, of all grades, was frequently described for cases of SIDS (n = 38/42). No coexistent signs or injuries were described, except for 1 case of bronchopneumonia.
17,18

Discussion
Despite the rarity of epistaxis in children aged <2 years, this review reiterates its association with asphyxiation, whether intentional or unintentional. Our findings confirm that young children do experience asphyxiation-related epistaxis, and estimate that between 7% and 24% of children presenting with epistaxis in the absence of trauma or medical causes have been asphyxiated. This review also underscores that detection of these children can be difficult.
A proportion of live children who were asphyxiated presented unwell with altered skin color, respiratory difficulty, and chest radiograph abnormalities, and a proportion had no reported signs of asphyxiation. However, in comparison, most live children who were not asphyxiated had no presenting signs and symptoms described other than epistaxis, despite examination and investigation. The past medical history, concurrent signs and injuries, and family histories of deceased children with non-asphyxia-related epistaxis were poorly described; the majority of these cases were classified as SIDS.
The finding of a clear association between epistaxis and asphyxiation in infants is supported by several studies, which did not meet this review's strict inclusion criteria. 10, [23] [24] [25] Meadow 23 analyzed 70 cases of child homicides (which included data from Southall et al 5 ) 39% of these children who were asphyxiated had frank blood in the mouth, in the nose, or on the face. Others noting this association classified children with epistaxis as at high risk for previous asphyxiation, but there was considerable circularity; epistaxis was a criterion used to classify the risk of asphyxiation. 24 Most live children who were asphyxiated included in this review presented with ALTEs, changes in skin color, or respiratory difficulty; however, some presented without any additional signs and symptoms, other than epistaxis. A symptomatic presentation is supported by a case report of perpetrator-admitted asphyxiation, describing an infant presenting as irritable, acidotic, and in respiratory difficulty requiring oxygen and with chest radiograph changes. 26 The significance of epistaxis in infants, even in the absence of coexistent signs or symptoms, was highlighted by Walton et al, 10 who reported a case of an apparently well 19-day-old n, total number of children with epistaxis; p, number of children with epistaxis who were asphyxiated.
baby with bilateral epistaxis discharged from the emergency room without senior review, who returned with multiple suspicious fractures. Given the rarity of the condition under review, our findings are limited by the paucity of large-scale, high-quality comparative studies addressing this question. The nature of systematic reviews conducted to determine clinical associations means that observational studies, such as those included in our review, are the sole source of high-quality evidence in this field. 27 Unfortunately, the included studies are thus at high risk of bias enhanced by the lack of a gold standard test for intentional asphyxiation, if relevant. In addition, the information presented was often incomplete, for example, lack of details on coagulation screening. We included children who received CPR, given that the quality of CPR in the community is variable and often inadequate. 28 We included live and dead children, although the significance of epistaxis in relation to asphyxiation may vary between these populations. The application of our quality standards enhanced the validity of findings, but limited the studies eligible for inclusion.
The American Academy of Pediatrics has stated that numerous circumstances can indicate intentional asphyxiation, including recurrent cyanosis, apnea, or ALTEs in the care of the same person; age >6 months at death; an unexplained or unexpected sibling death; simultaneous or nearsimultaneous death in twins; deaths of infants under the care of the same unrelated person; and evidence of pulmonary hemorrhage. 29 Our findings support most of these recommendations, but this review found insufficient evidence to be categorical about associated features.
Any child aged <2 years presenting with epistaxis, in the absence of witnessed trauma or a clear medical cause, should receive a full clinical assessment to explore the possibility of asphyxiation or occult trauma, in addition to organic causes. This presentation warrants a full investigation, including a complete examination and review by an otolaryngologist, coagulation screening, and a comprehensive family and social history. In addition, these children should be investigated for suspected maltreatment in line with the standard recommendations for this age group, which would include skeletal surveys and head imaging in those aged <1 year and skeletal scans for those aged 1-2 years. 30 n We thank Mala Mann (Cardiff University) for advising on the design of search strategies, and Alun Tomkinson and Richard Jones, MD, for their input into the review's inclusion and exclusion criteria. N ancy Huang (pulmonologist), Rob Harley (ophthalmologist), and others from St. Christopher's Hospital for Children report the novel occurrences of optic neuritis or retrobulbar neuritis in 9 of 33 patients receiving chloramphenicol in late stages of cystic fibrosis. The cases are described perfectly: drug doses, long durations of therapy, symptoms of visual loss, retinal abnormalities, and improved courses after discontinuation of drug, with or without vitamin B complex administration. How frequently in medical science does the early report of a condition include the description, hypothesis of pathophysiology, experiential observation of proof of concept, and then path to resolution? The authors observed in their conclusions, as open-minded scientists, that these cases of optic neuropathy could be due to drug toxicity, drug hypersensitivity, or drug-associated vitamin deficiency. This was a time when chloramphenicol was used eagerly, and with knowledge of idiosyncratic bone marrow suppression, as a lifesaving treatment for children with Hemophilus influenzae type b meningitis and other serious antibiotic-resistant infections.
This writer had the privilege of working with Dr Huang and Dr Harley at St. Christopher's in the 1970s. Dr Huang had amassed a population with cystic fibrosis of well over 300 patients. There never was a time in the 1970s without one of her terminal middle-school patients in the hospital. Younger affected siblings observed what would be their fate and parents mourned loss of more than 1 child after their prolonged painful deterioration.
Nancy Huang was their hero. Standing at 5 feet on a tall day, she had a constant wide smile and sparkling eyes and the fierce fight of a mother bear for her cubs. As a trainee in infectious diseases, sharing a train ride with Dr Huang to Washington, DC for the annual Interscience Conference on Antimicrobial Agents and Chemotherapy antibiotic meetings, this writer remembers vividly 2 conversations. In the first, she told me that she was going shopping at ICAAC for a new antibiotic to help her sick patients. In another, I learned that she did relax, treating herself to gardening for 45 minutes every single Sunday. Married to Peter Kuo, MD, a ground-breaking lipid scientist at the University of Pennsylvania, this couple literally dedicated their lives to science and service, and had enormous impact not only on science and suffering but on countless trainees such as me. 
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